Takeda Pharmaceutical Company Limited
4-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139

Abstract:

The present invention provides a method for treating a disease, disorder or condition associated with GPR139 using compounds of formula 1: ##STR00001## which are agonists of GPR139, certain compounds encompassed by formula 1, pharmaceutical compositions thereof, processes for making the compounds, and intermediates thereof.